Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
about
Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cellsCloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysisCell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinasesVEGF-initiated angiogenesis and the uPA/uPAR systemThe urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motilityInvolvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesisAccessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitorPlasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosisSecretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules.The role of plasminogen activators in the regulation of connective tissue metalloproteinases.The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells.Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin.Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides.In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells.The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.Plasminogen activator-dependent pericellular proteolysis.Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation.Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.The fibrinolytic system of the vessel wall and its role in the control of thrombosis.Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences.The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.Elimination of hydrocortisone from the medium enables tissue plasminogen activator gene expression by normal and immortalized nonmalignant human epithelial cells.
P2860
Q24297830-567FB098-7C67-4834-A5F0-321513593365Q24299135-DBB049E6-3259-49F9-8EBD-A98D60A13B4FQ24672373-5920A42A-2946-4F48-BC5A-55BF1F054B63Q27025897-70B0641A-C797-473F-86AA-75ED282DEC46Q28212178-216E591D-EC70-4169-BDB2-3818192AB7F6Q28582277-F8E21B1F-CCED-4D0F-8D35-DB4600F84A62Q28647054-0D50E463-216B-44EB-A2D8-046EA51298ACQ33781945-0809CF9D-883C-4DEA-8522-942CCFBDFC78Q34372572-A0E16867-6E77-44E3-B913-C216BCD53EA3Q34379086-09C29893-2E93-4DA7-B075-A83C58F172AFQ34632691-5DE4AB98-5033-4186-951F-BAB8BC182A11Q35240608-768744D6-873B-4102-A62E-A71F60CDF6F3Q35240620-F9598DF6-72C1-4A6B-8348-2F122D045D5DQ35352896-DA60D036-DFA7-46D1-813F-ACB7BA30716AQ35594636-94461782-D611-4A41-A7C6-07498005980AQ35796413-C5C37125-7D53-4ECE-98E0-7F4FA4BD19E8Q36217085-D3B8807B-1C06-4D05-8F43-77E4FA488830Q36218449-E849117E-0E9A-4DA1-8F92-5A05EED3EAD3Q36218753-93396603-BBAB-4107-BC6F-728C110D5A69Q36220034-05F59D07-35E7-407F-98DD-6866996076BBQ36220582-9C26960D-4350-4F98-BD93-D536B50E1313Q36221277-5EB41EC6-C26A-4390-A07E-F35B6E033A70Q36222413-B38BEE3E-C954-4C00-B897-D08484949CC8Q36223450-596EEC3E-CB26-4023-A18B-E45CF6BC5972Q36223752-86927B52-B908-4CC6-AB75-315D8B350305Q36223980-3C1B8F0C-CD9B-4106-ADAA-C460FD464FF6Q36292147-6F7179FD-FAE4-4DD3-9C31-5CD03FDD2B28Q36382514-8919116E-8F6E-4C6B-9721-881E7056F25FQ36457877-324B1E9D-3BA8-4A5C-B5B1-BB72919E2E0EQ36641938-D7A926D1-35C2-445A-BA9B-C88CB8CE52E0Q36741529-3B9AECBC-318B-4D42-9906-BA016CEC5CE1Q36772566-586416C7-35EF-495F-9675-198A96967486Q36920255-4F285445-4680-4DD6-AB46-4EAC2E2F0400Q37300380-CF281936-07BA-462C-B6ED-72719EBF1164Q37720834-86B826A8-11A4-44DD-B844-2E6B0B0E06AAQ38000918-564363F6-9598-4BBE-A7CE-A9CE64437C63Q40444813-3A63C4C9-1041-419F-BA0F-8272FD84B9FDQ40642393-5C0D090E-34C9-40E9-845A-DA871F37B30CQ40642836-D0BA095F-40B3-452C-8995-C9E6B24667EDQ40760205-F6CA10D8-C7C5-427D-BBCF-FD451D280721
P2860
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Distinct localizations of urok ...... fibroblasts and sarcoma cells.
@en
type
label
Distinct localizations of urok ...... fibroblasts and sarcoma cells.
@en
prefLabel
Distinct localizations of urok ...... fibroblasts and sarcoma cells.
@en
P2093
P2860
P356
P1476
Distinct localizations of urok ...... fibroblasts and sarcoma cells.
@en
P2093
Andreasen P
Pöllänen J
Salonen EM
P2860
P304
P356
10.1083/JCB.104.4.1085
P407
P577
1987-04-01T00:00:00Z